BioVie Inc.
Last updated September 27, 2026
Organization details
- Legal name
- BioVie Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- BIVI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001580149
Board of directors
-
Amy Suzon Chappell · DirectorSince 2025
-
Cuong Do V · Director · President & CEOSince 2023
-
James Paul Lang · DirectorSince 2023
-
Kameel D. Farag · DirectorSince 2025
-
Michael Edward Sherman · DirectorSince 2023
- Since 2023
-
Robert J. Hariri · DirectorSince 2023
-
Sigmund Rogich · DirectorSince 2023
-
Steve Gorlin · DirectorSince 2023
-
Terren S. Peizer · DirectorSince 2023
Chief executives
Cuong Do V
· President & CEO
Dates unknown
Board connections
4 of this board's directors also sit on 8 other boards.
- via Richard J. Berman and Robert J. Hariri
- via Richard J. Berman and Robert J. Hariri
- via Cuong Do V
- via Richard J. Berman
- via James Paul Lang
- via James Paul Lang
- via Richard J. Berman
- via Cuong Do V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $49,118
- 4 purchases by 4 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 2026 | KIM JOANNE WENDY Officer (Chief Financial Officer) | Open-market purchase | +2,500 | $2.18 | $5,450 |
| Aug 28, 2026 | Amy Suzon Chappell Director | Open-market purchase | +727 | $2.16 | $1,570 |
| Aug 28, 2026 | Palumbo Joseph M Officer (Chief Medical Officer) | Open-market purchase | +4,843 | $2.16 | $10,461 |
| Aug 27, 2026 | Cuong Do V Director, Officer (President & CEO) | Open-market purchase | +15,210 | $2.08 | $31,637 |
| Aug 7, 2025 | Cuong Do V Director, Officer (President & CEO) | Open-market purchase | +5,000 | — | — |
| Nov 20, 2024 | Sigmund Rogich Director | Grant or award | +32,700 | — | — |
| Nov 20, 2024 | Richard J. Berman Director | Grant or award | +34,200 | — | — |
| Jun 24, 2024 | Palumbo Joseph M Officer (Chief Medical Officer) | Grant or award | +116,000 | — | — |
| Jun 24, 2024 | KIM JOANNE WENDY Officer (Chief Financial Officer) | Grant or award | +73,000 | — | — |
| Jun 24, 2024 | Cuong Do V Director, Officer (President & CEO) | Grant or award | +168,000 | — | — |
| Jun 24, 2024 | Palumbo Joseph M Officer (Chief Medical Officer) | Shares withheld for tax | −29,000 | $0.47 | $13,630 |
| Jun 24, 2024 | KIM JOANNE WENDY Officer (Chief Financial Officer) | Shares withheld for tax | −18,250 | $0.47 | $8,578 |
| Jun 24, 2024 | Cuong Do V Director, Officer (President & CEO) | Shares withheld for tax | −42,000 | $0.47 | $19,740 |
| Mar 4, 2024 | Cuong Do V Director, Officer (President & CEO) | Open-market purchase | +10,000 | — | — |
| Feb 15, 2024 | Palumbo Joseph M Officer (Chief Medical Officer) | Shares withheld for tax | −2,476 | $1.18 | $2,922 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.